AU2001240556A1 - 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents - Google Patents

5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents

Info

Publication number
AU2001240556A1
AU2001240556A1 AU2001240556A AU4055601A AU2001240556A1 AU 2001240556 A1 AU2001240556 A1 AU 2001240556A1 AU 2001240556 A AU2001240556 A AU 2001240556A AU 4055601 A AU4055601 A AU 4055601A AU 2001240556 A1 AU2001240556 A1 AU 2001240556A1
Authority
AU
Australia
Prior art keywords
dispersed
aminolevulinic acid
aqueous solvents
acid formulation
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001240556A
Other languages
English (en)
Inventor
Antje Bunke
Gerd Burmeister
Bruno Gander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ASAT AG Applied Science and Technology
Original Assignee
ASAT AG Applied Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7628975&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001240556(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ASAT AG Applied Science and Technology filed Critical ASAT AG Applied Science and Technology
Publication of AU2001240556A1 publication Critical patent/AU2001240556A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001240556A 2000-01-28 2001-01-29 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents Abandoned AU2001240556A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10003620A DE10003620A1 (de) 2000-01-28 2000-01-28 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln
DE10003620 2000-01-28
PCT/EP2001/000930 WO2001055092A2 (de) 2000-01-28 2001-01-29 5-aminolävulinsäure-formulierung in nichtwässrigen lösungsmitteln

Publications (1)

Publication Number Publication Date
AU2001240556A1 true AU2001240556A1 (en) 2001-08-07

Family

ID=7628975

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001240556A Abandoned AU2001240556A1 (en) 2000-01-28 2001-01-29 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents

Country Status (12)

Country Link
US (1) US20030125388A1 (de)
EP (1) EP1255725B1 (de)
JP (1) JP2003526637A (de)
AT (1) ATE455090T1 (de)
AU (1) AU2001240556A1 (de)
CA (1) CA2399405C (de)
CY (1) CY1109948T1 (de)
DE (2) DE10003620A1 (de)
DK (1) DK1255725T3 (de)
ES (1) ES2335475T3 (de)
PT (1) PT1255725E (de)
WO (1) WO2001055092A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2248536A3 (de) * 2000-12-14 2010-12-08 The General Hospital Corporation doing business as Massachusetts General Hospital Topische aminolevulinsäure-photodynamische therapie für akne vulgaris
CA2422865C (en) * 2000-08-16 2012-10-16 The General Hospital Corporation D/B/A Massachusetts General Hospital Aminolevulinic acid photodynamic therapy for treating sebaceous gland disorders
DE10301917B4 (de) * 2003-01-17 2007-02-01 Gerhard Saalmann Verwendung von Substanzen der Porphyrinsynthese bei der Phototherapie von Haut- oder Gelenkerkrankungen des Menschen oder von Säugetieren
GB0424833D0 (en) * 2004-11-10 2004-12-15 Photocure Asa Method
US8419341B2 (en) 2006-09-19 2013-04-16 Brooks Automation, Inc. Linear vacuum robot with Z motion and articulated arm
EP1938801A1 (de) * 2006-12-22 2008-07-02 Biofrontera Bioscience GmbH Nanoemulsion
WO2008106966A1 (en) * 2007-03-06 2008-09-12 Christiansen Kaare A method for non-therapeutic or therapeutic photodynamic skin treatment
WO2009003173A1 (en) 2007-06-27 2008-12-31 The General Hospital Corporation Method and apparatus for optical inhibition of photodymanic therapy
GB0724279D0 (en) * 2007-12-12 2008-01-23 Photocure Asa Use
JP5081121B2 (ja) * 2008-10-17 2012-11-21 株式会社ミルボン 育毛剤組成物
CA2763837A1 (en) * 2009-06-11 2010-12-16 Photocure Asa Solid compositions comprising 5-aminolevulinic acid
EP2440199B1 (de) 2009-06-11 2016-04-13 Photocure ASA Halbfeste pharmazeutische zusammensetzungen
JP5574329B2 (ja) * 2010-05-06 2014-08-20 国立大学法人 岡山大学 ミトコンドリアの蛍光染色方法
CN103270168A (zh) 2010-12-24 2013-08-28 爱科来株式会社 癌细胞的检测方法
CN112010772A (zh) 2016-01-26 2020-12-01 赵鸣 5-氨基酮戊酸及其衍生物的盐化合物和应用
ES2638239B1 (es) * 2016-03-18 2018-08-09 Consejo Superior De Investigaciones Científicas (Csic) Procedimiento de monitorización de digestores anaerobios
CN108434100A (zh) * 2018-04-27 2018-08-24 中南大学湘雅三医院 一种用于光动力疗法治疗鼻咽喉腔疾病的喷雾光敏剂组合物
WO2023180282A1 (en) 2022-03-24 2023-09-28 Evonik Operations Gmbh Co-precipitates of methionylmethionine with organic compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
DE4320871C2 (de) * 1993-06-24 1995-05-04 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an delta-Aminolävulinsäure
AU3176695A (en) * 1994-09-20 1996-04-04 Johnson & Johnson Medical, Inc. Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid
DE69613365T2 (de) * 1995-03-10 2002-05-02 Photocure Asa Oslo Oslo Ester der 5-aminolevulinsäure als mittel zur photosensibilisierung in der chemotherapie
JP3644809B2 (ja) * 1997-10-15 2005-05-11 コスモ石油株式会社 頭部用外用剤
US5954703A (en) * 1997-10-31 1999-09-21 Dusa Pharmaceuticals, Inc. Method and apparatus for applying 5-aminolevulinic acid
FR2777782B1 (fr) * 1998-04-22 2001-05-18 Alexandre Marti Solution pour la preparation d'une substance pharmaceutique pour le diagnostic et/ou le traitement de lesions tissulaires

Also Published As

Publication number Publication date
PT1255725E (pt) 2010-03-31
DE50115306D1 (de) 2010-03-04
EP1255725A2 (de) 2002-11-13
EP1255725B1 (de) 2010-01-13
US20030125388A1 (en) 2003-07-03
CY1109948T1 (el) 2014-09-10
WO2001055092A3 (de) 2002-02-14
CA2399405C (en) 2010-03-23
ES2335475T3 (es) 2010-03-29
JP2003526637A (ja) 2003-09-09
ATE455090T1 (de) 2010-01-15
DK1255725T3 (da) 2010-04-26
WO2001055092A2 (de) 2001-08-02
WO2001055092B1 (de) 2002-03-07
CA2399405A1 (en) 2001-08-02
DE10003620A1 (de) 2001-08-02

Similar Documents

Publication Publication Date Title
CY1109948T1 (el) Συνθεση του 5-αμινολεβουλινικου οξεος σε μη υδατικους διαλυτες
CO5271759A1 (es) Formulacion en solucion que contiene una mezcla de disolventes
Lopez et al. Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters
US4021538A (en) Method for producing pigmentation in hair or skin
US5955067A (en) Potassium-containing composition useful in the treatment of acne, psoriasis and seborrhea
Ohshima et al. Induction of DNA strand breakage and base oxidation by nitroxyl anion through hydroxyl radical production
DE3679722D1 (de) Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung.
KR20080027765A (ko) 국소적 손톱 및 발톱용 제형제
BR0313343A (pt) Uso de uma mistura de agentes permeantes, soluções para aplicação ungueal e periungueal e uso de uma solução para aplicação ungueal e periungueal
EE03292B1 (et) Prootonpumba inhibiitorit sisaldav paljuosaline ravimpreparaat ja selle valmistamise protsess
BR9508779A (pt) Derivados de rodamina fototivávies uso dos mesmos e processos para terapia fotodinâmica de um paciente e para purga in vitro de medula óssea
KR910014103A (ko) 사람의 손톱 처리용 국소 제제
Wiebe et al. Oxidation photosensitized by tetracyclines
JPH08175986A (ja) 経皮活性を示す５−アミノレブリン酸含有薬学組成物
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
DK1300143T3 (da) Plaster som indeholder 4-biphenyleddikesyre
Deliconstantinos et al. Inhibition of ultraviolet B-induced skin erythema by N-nitro-L-arginine and N-monomethyl-L-arginine
US20010004642A1 (en) Amino fruit acid composition and method for the treatment of skin
AU2001258859A1 (en) Pralmorelin-containing nasal drop preparations
DE59801192D1 (de) Delta-aminolävulinsäure enthaltendes arzneimittel
AU2003246663A1 (en) Use of compositions comprising salicylic acid and glycyrrhetinic acid for the treatment of acne
WO1994006405A1 (en) Method for the treatment and/or prevention of radiation burn
CA2414921A1 (en) Use of diclofenac for treatment of burns
CA2243657A1 (en) Compositions for treatment of erectile dysfunction
SU1526689A1 (ru) Способ лечени аллергодерматозов химического генеза